Product Name:4-bromo-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile

IUPAC Name:4-bromo-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile

CAS:2068065-05-2
Molecular Formula:C8H4BrN3O
Purity:95%+
Catalog Number:CM325559
Molecular Weight:238.04

Packing Unit Available Stock Price($) Quantity
CM325559-100mg in stock ſƱ
CM325559-250mg in stock Ʊſȷ
CM325559-1g in stock ȷſDz

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:2068065-05-2
Molecular Formula:C8H4BrN3O
Melting Point:-
Smiles Code:N#CC1=C2C(Br)=CC(O)=CN2N=C1
Density:
Catalog Number:CM325559
Molecular Weight:238.04
Boiling Point:
MDL No:
Storage:

Category Infos

Pyrazolopyridines
Over the past few years, many pyrazole fused-ring systems, especially with applications in medicinal chemistry, have been published. These include general structures such as pyrazoline, pyrazoline, pyrazoquinoline, pyrazoloisoquinoline, pyrazoline, pyrazolopyrazine, pyrazolopyrazine, pyranopyrazole, pyrano Pyrazoles, pyrazolotriazines and pyrazole fused phosphorus rings.

Column Infos

Selpercatinib
The FDA has granted accelerated approval to selpercatinib (Retevmo; Eli Lilly and Company) for pediatric patients aged 2 years and older with RET-altered metastatic thyroid cancer or solid tumors, the federal agency announced in a press release. Selpercatinib is a highly selective, potent RET inhibitor. It works by blocking a type of enzyme (kinase) and helps prevent the cancer cells from growing.

Related Products